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Abstract 
This study improves a simple strategy for phase transfer process via ultrasonication approach. Water-soluble AgInS2-ZnS 
quantum dots (QDs) encapsulated with oleylamine have been successfully prepared without the presence of surfactant or 
polymer. During the propagation process, ultrasonication creates harmonic pressure (relative to the equilibrium hydrostatic 
pressure of the liquid), which was helpful for the dispersion of nanomaterials in two immiscible phases. The highly 
photoluminescent ZnS coated AgInS2 QDs (up to 55.3% QY) was synthesized with a one-pot two-step process with narrow 
particle distribution and successfully transferred to water phase without significant effect on optical properties. Beside QDs 
characterization, some factors such as pH stability, ionic strength, and bonding properties were investigated to reach a good 
condition of water soluble AgInS2-ZnS QDs. These nanoparticles also showed potential application for cancer cell staining. To 
demonstrate the targeting capability, folic acid was further conjugated with oleylamine encapsulated AgInS2-ZnS QDs for HeLa 
and MCF7 cancer cell staining. This study also reveals that the water-soluble QDs still gave lower fluorescence intensity on 
confocal imaging, even without folic acid conjugation. Moreover, folic acid is efficiently internalized into cells through folate 
receptor-mediated endocytosis. Confocal imaging characterization further informs folic acid-conjugated AgInS2-ZnS QDs that 
could specifically be targeted to the human cervical (HeLa) cells. 
© 2015 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of the organizing committee of the Molecular  and Cellular Life Sciences: Infectious Diseases, 
Biochemistry and Structural Biology 2015 (MCLS 2015). 
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1. Introduction 
Over the last decades, nanoparticles have been prepared as attractive materials with excellent results for many 
applications. As one kind of nanoparticles, QDs have been proposed as ideal candidates for optical bioanalysis due 
to their electronic and optical properties, which can be tuned by changing the size, morphology, and composition of 
the nanoparticle. For several aspects, QDs can give more benefit in its application compared with organic dyes. QDs 
have tunable fluorescence signatures, broad excitation but specific emission spectra, bright emission, good 
photostability, along with potential for both static and kinetic in-vivo imaging1, 2. Currently, toxicity pro¿le and the 
strategy to get high performance QDs still become important aspects relating QDs application to biological purpose. 
Synthesis of I-III-VI nanocrystal QDs, like AgInS2 QDs, is the best way to reduce toxicity problems in application of 
QDs. Moreover, further efforts to increase photoluminescence have been pursued3,4. Previous study showed 
increased photoluminescence by introducing ZnS shell onto AgInS2 QDs5. Beside acting as a barrier for dissolving 
AgInS2 QDs with the surrounding solvent through ionization, ZnS also reduce the toxicity effect of the application of 
AgInS2 QDs on biological environment. 
Because only hydrophilic matter that can be applied for bio-applications, synthesis routes to produce high quality 
water soluble QDs became another problem of hindering use of QDs for bio-applications. AgInS2 is usually 
synthesized as a hydrophobic material due to the need to obtain high monodispersity of QDs and high 
photoluminescence with wide emission color range6,7. This can even be made directly in water. The result that 
AgInS2-ZnS QDs have poor size ranges and wide size distribution that lead to wide of Full width at half maximum 
(FWHM) and low %QY8-10. Therefore, a phase transfer method became an important step connecting the application 
of high quality QDs to biomedical use. Development of a phase transfer strategy, so far, addressed the challenge to 
get highly efficient and effective QDs for their application. Several phase transfer strategies were developed, such as 
modifying QDs with long sequence surfactant, like biological molecules11, proteins12-14,  DNA15,16, and polymers17. 
Most of them gave problematic degradation of optical properties due to aggregation of the QDs. To avoid 
aggregation and achieve stable colloidal QDs, alternative phase transfer protocols apply small molecule surfactant 
through ligand exchange and formation of a double layer encapsulated ligand on the surface of QDs18-22. Compared 
with the ligand exchange process, encapsulation of small surfactants as a second layer is the preferred strategy for 
making generally targeted nanoparticles and protecting QDs from prejudicial chemical reactions20, 23, 24. 
The application of small surfactants for transferring QDs was discussed in several studies, even though most of 
the resulted QDs suffered low stability and lose the specific binding with target biomolecules25. The successful 
application of small surfactant on phase transferring QDs was performed by Prakash et al., who used oleic acid as a 
second layer on hydrophobic QDs and generated highly stable QDs in a wide concentration range, at various 
temperature and pH26. In our previous publication, we described the potential of fatty acid for delivering oil-soluble 
QDs to the water phase, along with its potential on reacting with the pterin ring of folic acid to perform specific up 
take of the QDs on cancer cell24. However, folic acid is a cell nutrient which is taken up by the cell through the folate 
receptor (FR). The pterin ring of folic acid is the responsible part for binding FR on the cell membrane, so its 
modification will affect the cell’s folate uptake process27,28. Therefore, designing nanoparticles that can react with 
folic acid along with preserving its pterin part is a crucial factor. A fatty amine, like oleylamine, is a good candidate 
that can conjugate with the glutamic acid part of folic acid though amide formation. In this research, we propose a 
simple and effective phase transfer strategy of AgInS2-ZnS QDs by using oleylamine (OA) as a small molecule 
surfactant. Ultrasonication treatment was introduced to promote self-assembly of the surfactant. We show that van 
der Waals bonding between a second layer ligand with first layer ligand was a safe process for facile phase transfer. 
Then, potential application of water-soluble QDs for bioimaging of several cancer cell lines have been investigated 
after folic acid (FA) conjugation. 
2. Methods 
2.1. Synthesis of AgInS2-ZnS QDs 
The mixture containing AgOAc (0.16 mmol), InOAc (0.29 mmol), 2.5 mL of 1-Dodecanethiol (DDT), and 5 mL 
of Octadecene (ODE) was mixed in a three neck flask fitted with a condenser and a thermometer. Starting with 
degassing under vacuum, the mixture was purged three times with argon, and heated at 60°C for 30 minutes. The 
resulting solution was subsequently heated to 220°C for 30 minutes. The injection solution of the ZnS precursor was 
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prepared by mixing zinc stearate (0.79 mmol) in 3 mL ODE with 31 mg of zinc ethyl xanthate in a solvent mixture 
containing 300 ȝL of dimethylformamide and 1 mL of toluene. ZnS precursors were added drop wise by means of a 
syringe pump (KD Scientific KDS100, USA) at a flow rate of 0.13 mL miní1. After the injection was complete, the 
reaction mixture was cooled to room temperature, followed by centrifugation at 6000 rpm for 20 minutes. The 
precipitate was then discarded and the supernatant was washed in 5 mL chloroform and 7.5 mL methanol for three 
times followed by 20 minutes of centrifugation at 6000 rpm after the addition of 40 mL of acetone. The supernatant, 
which contained unreacted material, was discarded and the remaining precipitate was left at room temperature to 
remove the solvent. 
2.2. Preparation of oleylamine encapsulated AgInS2-ZnS (QDs@OA) 
A hexane solution of QDs (10 mL, 40 mg mL–1) was mixed with 0.252 mmol of oleylamine and the mixture was 
sonicated for 30 minutes. Then, 10 mL of 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution (pH 7.4) was 
added. Ultrasonication (VCX 130 PB, 130 W, 20 kHz, Sonics and Materials Inc., Newton, CT) was implemented by 
immersing the ultrasonic probe into the mixture until the hexane and aqueous phase turned white and cloudy. The 
mixture was centrifuged at 6000 rpm for 10 minutes to speed up the separation of the hexane and aqueous phases. 
Then, the aqueous solution was extracted and passed through 0.22 ȝm filter to remove aggregated QDs. The QD 
solution was further purified to remove excess oleylamine by tangential ultrafiltration with a polyethersulfone 
membrane (MWCO 3000 Da; Cellu Sep H1, Orange Scientifique, Belgium). 
2.3. Preparation of FA-conjugated AgInS2-ZnS (QDs@OA-FA) 
A colloidal solution of QDs@OA-FA was synthesized by adding 0.13 mmol of n-ethyl-N’-(3-
dimethylaminopropyl) carbodiimide (EDC) and 0.17 mmol of N-hydroxysulfosuccinimide sodium Salt (NHS) into 
folic acid (FA) (0.05 mmol) dissolved in MES buffer (20 mL). The reaction was maintained at room temperature for 
30 minutes under conditions of moderate stirring. The QDs@OA was then added to the activated FA solution, and 
the mixture was stirred gently for 24 hours at room temperature in the dark. The FA conjugated AgInS2-ZnS QDs 
were purified by centrifugation at 10,000 rpm for 10 minutes and washed three or four times with MES (pH 7.4).  
2.4. Toxicity Study with MTT Assay 
The MTT (thiazolyl blue tetrazolium bromide) tests were respectively carried out with HeLa cells cultured at 24 
hours, which was used to evaluate the cell activity and its viability. The MTT assay is a colorimetric assay for 
measuring the activity of enzymes that reduce MTT giving a purple color. In the first step, the cultured cells were 
washed three times with PBS, and 1 mL MTT solution (0.1 mg/mL) was added into the culture dishes for 4 hours at 
37°C. Then, the formazan dye was dissolved in DMSO and quantified by using ELISA reader at a wavelength of 
570 nm. 
2.5. Cell Culture and Observation of Intracellular Location of QDs with Confocal Microscopy 
The HeLa and MCF-7 cells were cultured in Eagle’s minimal essential medium (containing 1.5 g/L sodium 
bicarbonate) supplemented with 1% L-glutamine, 1% antibiotic/antimycotic formulation, and 10% fetal bovine 
serum. To induce cell expansion and senescence, the cells were cultured in a humidified 5% CO2 atmosphere at 
37°C. MCF-7 and HeLa cells were seeded in a six-well plate in 2 mL of culturing medium 24 hours before QDs 
feeding. After 1 hour of incubation with 300 ȝL of QDs, the cells were washed three times with PBS and then fixed 
with 75% alcohol for 10 minutes. Then, the fixed cells were incubated for 20 minutes at room temperature with 2 
mL (0.05 ȝg/mL) DAPI in PBS for nucleus staining. Fluorescence images of the HeLa cells were acquired using an 
inverted confocal microscope (Leica TCS SP2, Leica Microsystems) equipped with a 63 × 1.32 NA oil immersion 
objective. Confocal images were obtained by illuminating the samples with the in-line Ar (488 nm) and He-Ne 
(503–680 nm and 588 nm) lasers. 
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2.6. Characterization 
Fourier transform infrared (FTIR) spectra were acquired by using a Bio-Rad FTS-3500. The ultrastructure of the 
nanocrystals was examined by a high resolution (HR) TEM equipped with an energy-dispersed X-ray (EDX) 
detector operated at an accelerating voltage of 200 kV. X-ray diffraction (XRD) samples were prepared by 
depositing the nanocrystals on a Si(100) wafer; XRD measurements used a Rigaku 18 kW rotating anode source X-
ray diffractometer with the Cu KĮ1 line (Ȝ = 1.54 Å). UV-vis absorption spectra were measured with a JASCO V-
670 spectrometer. The measurements of photoluminescence (PL) spectra were carried out by using a JASCO FP-
6500 spectrofluorometer equipped with a 150 W xenon lamp. The PL quantum yield (QY) of various samples were 
comparatively studied by taking rhodamine 6G (R6G) as a reference fluorescent dye with known QY (95%) and 
comparison of the integrated fluorescence intensity of the solutions; both recorded samples had the same absorbance 
(< 0.1 a.u., to minimize possible reabsorption effects). Dynamic light scattering (DLS) data were collected by using 
a Malvern instrument Zetasizer Nanoseries 3000 HS with He/Ne laser at 13° scattering angle. Cell viability was 




Fig. 1. (a) Diffractograms of AgInS2 and AgInS2-ZnS; TEM (left) and (b) HR-TEM (right) images of AgInS2-ZnS; (c) along with EDS spectra of  
AgInS2-ZnS. 
3. Results and discussion 
3.1. Properties of Synthesized AgInS2-ZnS QDs 
The oil-soluble QDs were prepared using an integrated process including solvothermal synthesis of AgInS2, 
followed by a hot injection process for ZnS coating. In the initial process, nucleation of AgInS2 crystal on ODE was 
mediated with DDT as capping ligand and protective agent for QDs. By adding ZnS, however, this can increase 
luminescence properties of AgInS2 without intermediate purification of core AgInS2 (%QY up from 28.8 to 75.3). 
The wide range band of ZnS (3.91 eV) minimizes both surface and intrinsic core defects leading to non-radiative 
relaxation and reducing the band-edge luminescence properties. In addition, ZnS also shrouds the AgInS2 core to 
reduce its toxicity effect. Characterization of QDs structure was confirmed by XRD (Fig. 1a), which showed a 
tetragonal crystal structure peak pattern corresponding to JCPDS 75-0117. Moreover, ZnS coating contributed by 
shifting the peak to higher angle corresponding to JCPDS 77-2100 for ZnS cubic structure (sphalerite). The spherical 
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morphology and high monodispersity of AgInS2-ZnS QDs in hexane were evaluated by HRTEM. AgInS2-ZnS QDs 
are quasi-spherical particles with an average diameter of around 3.5 nm. The existence of well-resolved lattice 
planes in the inset of Fig. 1b demonstrates the good crystallinity of the nanocrystal with the inter-planar spacing of 
the (111) lattice planes of AgInS2, and both (200) and (220) lattice planes were also discovered for ZnS. EDS 




Scheme. 1. Schematic phase transfer of QDs under ultrasonic wave assistance 
 
3.2. Phase Transfer Process 
For the phase transfer step, oil-soluble QDs and oleylamine were initially dissolved in hexane solution. 
Considering oil-soluble QDs structure attributed with hydrocarbon of DDT, applying oleylamine as surfactants on 
this process gives the possibility of physical interaction among them. Moreover, the phase transfer process was 
accelerated by ultrasonic wave. Scheme 1 depicted that ultrasound intensively promotes hexane-in-water bubble and 
acoustic waves that causes both compression and expansion on the transmitting medium29. Once the bubbles are 
small enough, surfactant inside the bubble self-oriented, wherein long chain hydrocarbon encapsulates QDs and its 
hydrophilic moiety (amine site) is exposed on the outermost surface of QDs.  
Optical absorption and PL spectra (Fig. 2a) show insignificant change of QDs spectra after phase transfer process 
using oleylamine as surfactant. The first exciton peaks in absorption spectra (around 400-500 nm), which indicate 
minimal irradiative recombination at the surface sites of QDs consistently appeared after the phase transfer process. 
The wavelength of the maximum PL emission position (PL Omax) for DO/QDs in the aqueous phase at 550 nm was 
almost identical to the PL Omax for QDs in organic solution. Moreover, shifting PL Omax of quantum dots to lower 
wavelength, known as blue shift, occurred when ZnS was introduced to AgInS2. This blue shift indicates inter-
diffusion of the wider band gap of ZnS (3.91 eV) into the AgInS2 lattice, which has a narrower band gap (1.87 eV), 
during shell deposition.30 It was noticed that this strategy could maintain the emission of QDs and avoid aggregation 
after phase transfer, with slightly decreased %QY to 55.3 (from 75.3 of AgInS2-ZnS). 
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Fig. 2. (a) Normalized UV-vis absorption and PL (Ȝex = 430 nm) spectra of AgInS2, AgInS2-ZnS, and QDs@OA, respectively; (b) The 
photographs show initial QDs dissolved in chloroform as the bottom phase (i), and after phase transfer of QDs@OA (ii) in water (as upper 
phase), with the image under UV light on the right; (c) Hydrodynamic size of QDs before and after the phase transfer process; (d) 
Fouriertransform infrered (FTIR) spectra of bare QDs, QDs@OA, and bare Oleylamine. 
Fig. 2b proves that physical interaction among hydrocarbon of QDs and oleylamine was a safe way for phase 
transferring QDs. The colloidal stability of QDs can exists in water phase and still yields yellow emission as well as 
when it is in an organic phase. The facile transfer process was also supported by DLS data (Fig. 2c), where the 
diameter of QDs doubles in the water phase. Again, these data reveal that this strategy can minimize aggregation of 
QDs during the process. For structural characterization, the bare QDs, QDs@OA, and neat OA were compared by 
FTIR studies (Fig. 2d). In QDs@OA, which were composed of OA covering the surface of bare QDs, a broad band 
between 3100 and 3300 cm-1 was observed and assigned to an aliphatic NH2 stretching peak. The –NH bending 
vibration at 1620 cm-1 and the –NH2 wagging vibration at 748 cm-1 were both observed in QDs@OA and OA. The 
C–N stretching vibration was observed between 1000 and 1200 cm-1. Then, a band at 1680 cm-1 for QDs@OA and 
neat OA that can be attributed to the C=C stretching mode was not observed in the spectrum of pristine QD. These 
results provide qualitative information about OA molecules capped on the surface of pristine QDs, resulting in 
QDs@OA.  
 
Fig. 3. (a) PL images of QDs@OA in varying pH (3-12) after 24 hours; (b) PL images (at pH 7) with different NaCl concentrations (from left to 
right: 0 M, 0.15 M, 0.3 M, and 0.5 M). 
The pH and salt stability of transferred QDs was under concern due to further applications. In psysiological 
condition, especially in the human body, some parts of organism can have particular pH values apart from variation 
in salt concentration, for example the pancreas has the most basic pH of around 8, acidic intracellular compartment 
endosomes are around pH 5–6 and lysosomes have pH 4–531,32. For that reason, the designed QDs have to maintain 
stability across the pH range of the human body. Fig. 3 further shows fluorescent images of QDs@OA in the pH 
range 3-13. The colloidal QDs have good stability at pH 3-10. This result indicates that QDs@OA are tolerant to 
different pH conditions below the pKa of protonated oleylamine (about 10.7); at higher pH, the NH3+ groups become 
deprotonated, which indicates that OA/QDs are ionized to electrostatically stabilize the QDs. Furthermore, Fig. 3b 
showed salt stability of QDs@OA after 24 hours, where it remained stable at NaCl concentration up to 0.3 M.  
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Fig. 4. Cell viability study using MTT assay of HeLa cells after 24 hours treatment with QDs@OA (red) and QDs@OA-FA (pink). Also shown is 
the cell viability study of MCF7 cells after 24 hours treatment with QDs@OA (blue) and QDs@OA-FA (violet). 
3.3. Cytotoxcicity study with MTT assay 
A MTT assay was performed to evaluate the cytotoxicity and efficacy of addition FA on QDs@OA used in this 
study on HeLa and MCF7 cancer cell. The absorbance of formazan (produced by reduction of MTT by 
dehydrogenases in living cells) at 570 nm is directly proportional to the number of live cells. It is demonstrated in 
Fig. 4 that the amount of live HeLa cell after 48 hours incubation with both QDs@OA and QDs@OA-FA is still 
over 80% even when the concentration was increased up to 300 ȝg/mL. The same result was also found on MCF7 
cancer cell where both QDs@OA and QDs@OA-FA caused no harm to the living cells. This in vitro cytotoxicity 
study implies that phase transfer technique utilizing oleylamine can produce water soluble QDs that have a chance to 




Scheme. 2. Schematic illustration of FA conjugation on QDs@OA 
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3.4. Cancer Imaging Application  
To promote the efficacy of the QDs for cell targeting, FA was then conjugated into colloidal QDs. FA is used as 
cancer cell targeting agent because of its highly affinity for the folate receptor (KD ~100 pM), which is abundantly 
overexpressed on many kinds of cancer cell, but exhibits limited expression on healthy cells33,34. In this experiment, 
to make QDs specifically targeting cancer cells, FA was chemically bonded with QDs@OA using the Steglich 
reaction. Reagent pair (EDC/NHS) first reacts with the glutamic acid part of FA to form active intermediate which 
easily reacts with NH2 site of QDs@OA (Scheme 2). Conjugating FA onto QDs@OA generated QDs@OA-FA. The 
biocompatibility evaluations of QDs@OA-FA on cellular uptake were performed with confocal laser-scanning 
Àuorescence microscopy. After 1 hour incubation, QDs@OA-FA was found in the cytoplasm of human cervical 
(HeLa) and human breast (MCF7) cancer cells (Fig. 5a-b). However, compared with MCF7, fluorescence of 
QDs@OA-FA on HeLa cells was much brighter. The large number of folate receptors has been predicted to be 
responsible for these phenomena because the concentration of folate receptor on HeLa membrane is higher than 
MCF735. To make sure of the effect of folate receptor on receptor-mediated endocytosis of QDs, a confocal image of 
HeLa cell after 1 hour incubation with QDs@OA is also furnished in Fig. 5c. Without the promotion of FA, 
basically, QDs still can show penetration by macropinocytosis (nonspecific uptake, not mediated by receptors)36. 
However, these phenomena suggest that FA in the surface of QDs plays an important role in promoting receptor-
mediated endocytosis of QDs. 
 
 
Fig. 5. (a) Confocal images of MCF7 cell after 1 hour incubation with QDs@OA-FA; (b) Confocal images of HeLa cell after 1 hour incubation 
with  QDs@OA-FA; (c) Confocal images of HeLa cell after 1 hour incubation with QDs@OA. The confocal images (left to right) consist of 
visible light (cells), green fluorescence of QDs, blue DAPI emission of the nucleus and superimposed QDs and DAPI images. Bars showed 20 
μm. 
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4. Conclusions 
A simple and facile phase transfer strategy has been proposed in this study to provide water-soluble AgInS2-ZnS 
QDs by using oleylamine as the transfer agent. The strategy on coating AgInS2 QDs with ZnS is a good choice for it 
does not only support the QDs core, but also significantly increases optical properties of AgInS2 QDs. The ultrasonic 
wave organizes the oleylamine to be self-assembled on the surface of QDs via physical interaction that results in 
clear water-soluble QDs, which still maintain their optical properties. Notably, the oleylamine encapsulated QDs 
(QDs@OA) have good stability over a range of pH and ionic strength. The covalent conjugation of FA expedites 
internalization of QDs into HeLa and MCF7 cancer cell via folate receptor-mediated endocytosis. Due to abundant 
folate receptor, which is overexpressed on HeLa cells, cellular uptake of QDs@OA-FA in HeLa cells become much 
better than in MCF7 cells, indicated by stronger emission of QDs in the cytoplasm. The confocal and cytotoxicity 
data become great evidence to show the potency of QDs@OA-FA as a labeling agent. The strategy opens a chance 
for advanced application of QDs@OA for further clinical purposes. 
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